Foyesade Oluokun

Linebacker

Age: 29
Free Agency: 2025 (Void)
Accrued Seasons: 6
  • 2024 Salary Cap Charge: $21,750,668 (8.11% of cap)
  • 2024 Cash Payout: $15,000,000 (6.33% of spending)
  • 2024 Cash to Cap Ratio: 0.69
  • Contract Value: $45,000,000 ($15,000,000 APY)
  • Fully Guaranteed Money: $28,000,000
  • Contract Ranking: 4/212 at LB

Current Contract

(UFA, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated Signing BonusRoster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
RegularPer Game
202227$1,500,000$4,166,666$0$500,000$500,000$1,500,000$6,666,6662.8%
202328$1,080,000$6,750,666$0$500,000$500,000$1,080,000$8,830,6663.9%
2024 📝
March 18: Roster bonus due
29$13,000,000$6,750,668$1,000,000$500,000$500,000$0$21,750,6688.1%
202530Void$2,584,000VoidVoidVoidVoid$7,752,0003.0%
202631Void$2,584,000VoidVoidVoidVoid$00.0%
202732Void$2,584,000VoidVoidVoidVoid$00.0%
Total$15,580,000$25,420,000$1,000,000$1,500,000$1,500,000$2,580,000$45,000,000

Contract Notes

Foyesade Oluokun signed a three year contract with the Jaguars. Worth $45 million base value up to $46.5 million with Pro Bowl incentives. Oluokun received $28 million guaranteed at signing.

Cash Flows

- fully earned money
- unearned or partially earned money
$15M
$30M
$45M
202220232024
Cash Due$15,000,000$15,000,000$15,000,000
Running Cash$15,000,000$30,000,000$45,000,000
Career Earnings: $34,129,628
Career APY: $5,688,271
Potential Earnings: $49,129,628
Total Guarantees: $28,146,628
Largest Cash Payment: $15,000,000 (2022)
Largest Cap Number: $21,750,668 (2024)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
FalconsDraftedExpired20184$2,606,628$651,657$146,628$4,129,628158.4%$1,032,407
JaguarsUFAActive20223$45,000,000$15,000,000$28,000,000$30,000,00066.7%$15,000,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Falcons4$4,129,628$1,032,407$4,129,6280.0%$00.0%
Jaguars2$30,000,000$15,000,000$15,497,3320.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2018Falcons$480,000$36,657$0$0$0$0$516,6570.3%$626,628
2019Falcons$570,000$36,657$0$0$0$0$606,6570.3%$570,000
2020Falcons$750,000$36,657$0$0$0$0$786,6570.4%$750,000
2021Falcons$2,183,000$36,657$0$0$0$0$2,219,6571.2%$2,183,000
2022Jaguars$1,500,000$4,166,666$0$500,000$500,000$1,500,000$6,666,6662.8%$15,000,000
2023Jaguars$1,080,000$6,750,666$0$500,000$500,000$1,080,000$8,830,6663.9%$15,000,000
2024Jaguars$13,000,000$6,750,668$1,000,000$500,000$500,000$0$21,750,6688.1%$15,000,000
2025Jaguars$0$2,584,000$0$0$0$0$7,752,0003.0%$0
2026Jaguars$0$2,584,000$0$0$0$0$00.0%$0
2027Jaguars$0$2,584,000$0$0$0$0$00.0%$0
Total$19,563,000$25,566,628$1,000,000$1,500,000$1,500,000$2,580,000$49,129,628$49,129,628

Statistics

YearGames PlayedGames InactiveSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards
2018160048.4%41.4%0000000000000
2019160029.5%66.2%0000000000000
2020151082.8%19.2%7839319494204100
2021170098.2%0.9%10290214476301000
2022170098.5%16.1%128562121295002200
2023170099.8%21.3%111622.5138106101300

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$12,116,000$15,000,000
Injury Adjusted$12,116,000$15,000,000
test
OTC Valuation $3.1M $6.1M $9.2M $12.2M $15.3M APY $3.3M $6.7M $10M $13.3M $16.7M $4,826,000 $2,500,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.